Skip to main content
Premium Trial:

Request an Annual Quote

Illumina Nets $340M in Public Offering

NEW YORK (GenomeWeb News) – Illumina said today that it has raised net proceeds of $342.6 million in a public stock offering.
The company said that it sold 4,025,000 shares at $87.50 per share in the offering.
Goldman, Sachs was the sole manager of the offering.
Illumina said last week that it plans to use the proceeds from the offering to fund R&D efforts, expand its manufacturing capacity, and for working capital needs. The company said that it may also use the financing to acquire, license, or invest in other businesses, technologies, or products.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.